系统医学作为应对阿尔茨海默病的策略
Xiao Xue Zeng1, Jie Bangzhe Zeng2
1Department of Health Management, Centre of General Practice, The Seventh Affiliated Hospital, Southern Medical University, Lishui Town, Nanhai District, Foshan City, Guangdong Province, P.R. China.
Journal of Alzheimer's disease : JAD
|November 19, 2023
概括
阿尔茨海默病 (AD) 涉及粉样斑块和团. 系统医学为早期诊断和神经元重建提供了个性化的方法,以对抗AD进展.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 系统生物学 系统生物学
背景情况:
- 阿尔茨海默病 (AD) 的特点是粉样斑块 (Aβ1-40,Aβ1-42) 和神经纤维状,导致认知障碍.
- 阿尔茨海默病是一种复杂,异质的疾病,治疗选择有限,需要新的治疗策略.
- 神经退行和脑缩是慢性AD的标志,推动了神经元和脑组织重建的需要.
研究的目的:
- 探索系统医学在个性化阿尔茨海默病 (AD) 管理方面的潜力.
- 突出早期诊断和干预在预防AD中神经元损失方面的重要性.
- 审查新兴的生物技术用于神经重建和恢复AD患者的大脑功能.
主要方法:
- 对当前AD病理生理学和治疗方法的文献综述.
- 对综合医疗保健策略的系统医学原则的分析.
- 检查新的生物技术,如RNA基因疗法,干细胞和生物打印用于神经修复.
主要成果:
- 系统医学为AD的精确治疗和护理提供了一个整体框架.
- 早期检测和干预对于缓解认知衰退和神经退行至关重要.
- 新兴技术显示,降低神经炎症和恢复AD中大脑功能是有前途的.
结论:
- 系统医学与个性化护理相结合,代表了AD预防,诊断和治疗的有希望的战略.
- 对系统医学和先进生物技术的进一步研究对于有效的AD管理至关重要.
- 重建神经元和脑组织对于恢复阿尔茨海默病患者的功能至关重要.
更多相关视频
相关概念视频
Alzheimer's Disease: Overview
496
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
496
Alzheimer's Disease: Treatment
196
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
196
Dementia
117
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
117


